CopyFind

ZYTIGA®

103,43 R$

Max. consumer price (CMED)

Analogs of ZYTIGA®

Find cheaper analogs and generic equivalents for ZYTIGA®.

Ingredients

ਸਰਗਰਮ ਤੱਤ: abiraterone acetate


ਉਤਪਾਦ ਝਲਕ

About ZYTIGA®

ZYTIGA® is a medication containing the active ingredient abiraterone acetate. Abiraterone acetate, sold under the brand name Zytiga among others, is a medication used to treat prostate cancer. Specifically it is used together with a corticosteroid for metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (mCSPC).

Key Benefits & Uses

  • Used for: 1 INDICATIONS AND USAGE Abiraterone acetate tablets are indicated in combination with prednisone for the treatment of patients with Metastatic.
  • Use only as directed on the product label or by a healthcare professional.
  • Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

abiraterone acetate, the active ingredient in ZYTIGA®, is the pharmacologically active substance of this product. 1 INDICATIONS AND USAGE Abiraterone acetate tablets are indicated in combination with prednisone for the treatment of patients with Metastatic castration-resistant prostate cancer (CRPC) Metastatic high-risk castration-sensitive prostate cancer (CSPC) Abiraterone acetate tablet is a CYP17 inhibitor indicated in. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking ZYTIGA®. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use ZYTIGA® for extended periods without medical advice.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.